vs

Side-by-side financial comparison of ATLANTIC AMERICAN CORP (AAME) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $53.8M, roughly 1.5× ATLANTIC AMERICAN CORP). ATLANTIC AMERICAN CORP runs the higher net margin — 1.1% vs -38.1%, a 39.1% gap on every dollar of revenue. On growth, ATLANTIC AMERICAN CORP posted the faster year-over-year revenue change (20.8% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 7.2%).

The Atlantic Telegraph Company was a company formed on 6 November 1856 to undertake and exploit a commercial telegraph cable across the Atlantic Ocean, the first such telecommunications link.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

AAME vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.5× larger
PRCT
$83.1M
$53.8M
AAME
Growing faster (revenue YoY)
AAME
AAME
+0.6% gap
AAME
20.8%
20.2%
PRCT
Higher net margin
AAME
AAME
39.1% more per $
AAME
1.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
7.2%
AAME

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
AAME
AAME
PRCT
PRCT
Revenue
$53.8M
$83.1M
Net Profit
$577.0K
$-31.6M
Gross Margin
64.9%
Operating Margin
1.4%
-4.1%
Net Margin
1.1%
-38.1%
Revenue YoY
20.8%
20.2%
Net Profit YoY
128.9%
-27.9%
EPS (diluted)
$0.02
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAME
AAME
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$53.8M
$83.3M
Q2 25
$55.3M
$79.2M
Q1 25
$50.1M
$69.2M
Q4 24
$49.0M
$68.2M
Q3 24
$44.5M
$58.4M
Q2 24
$47.7M
$53.4M
Net Profit
AAME
AAME
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$577.0K
$-21.4M
Q2 25
$3.3M
$-19.6M
Q1 25
$802.0K
$-24.7M
Q4 24
$412.0K
$-18.9M
Q3 24
$-2.0M
$-21.0M
Q2 24
$-684.0K
$-25.6M
Gross Margin
AAME
AAME
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
AAME
AAME
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
1.4%
-27.8%
Q2 25
7.6%
-28.0%
Q1 25
2.1%
-39.7%
Q4 24
1.1%
-28.9%
Q3 24
-5.5%
-38.4%
Q2 24
-1.8%
-50.3%
Net Margin
AAME
AAME
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
1.1%
-25.7%
Q2 25
6.0%
-24.7%
Q1 25
1.6%
-35.8%
Q4 24
0.8%
-27.6%
Q3 24
-4.5%
-35.9%
Q2 24
-1.4%
-48.0%
EPS (diluted)
AAME
AAME
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$0.02
$-0.38
Q2 25
$0.15
$-0.35
Q1 25
$0.03
$-0.45
Q4 24
$0.01
$-0.34
Q3 24
$-0.10
$-0.40
Q2 24
$-0.04
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAME
AAME
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$34.4M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$109.5M
$347.7M
Total Assets
$430.9M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAME
AAME
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$34.4M
$294.3M
Q2 25
$46.4M
$302.7M
Q1 25
$35.9M
$316.2M
Q4 24
$35.6M
$333.7M
Q3 24
$23.0M
$196.8M
Q2 24
$21.2M
$214.1M
Total Debt
AAME
AAME
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
AAME
AAME
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$109.5M
$380.3M
Q2 25
$106.2M
$385.8M
Q1 25
$102.4M
$389.2M
Q4 24
$99.6M
$402.2M
Q3 24
$105.8M
$241.2M
Q2 24
$100.7M
$251.8M
Total Assets
AAME
AAME
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$430.9M
$511.5M
Q2 25
$429.3M
$513.1M
Q1 25
$388.4M
$519.4M
Q4 24
$393.4M
$534.0M
Q3 24
$387.0M
$374.1M
Q2 24
$386.0M
$374.4M
Debt / Equity
AAME
AAME
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAME
AAME
PRCT
PRCT
Operating Cash FlowLast quarter
$6.6M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
12.3%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
11.51×
TTM Free Cash FlowTrailing 4 quarters
$19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAME
AAME
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$6.6M
$-6.6M
Q2 25
$9.3M
$-15.0M
Q1 25
$-722.0K
$-17.0M
Q4 24
$4.8M
$-32.4M
Q3 24
$90.0K
$-18.8M
Q2 24
$416.0K
$-15.7M
Free Cash Flow
AAME
AAME
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$6.6M
$-9.5M
Q2 25
$9.1M
$-17.8M
Q1 25
$-986.0K
$-18.8M
Q4 24
$4.6M
$-33.6M
Q3 24
$58.0K
$-19.0M
Q2 24
$361.0K
$-16.8M
FCF Margin
AAME
AAME
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
12.3%
-11.4%
Q2 25
16.5%
-22.5%
Q1 25
-2.0%
-27.2%
Q4 24
9.3%
-49.2%
Q3 24
0.1%
-32.6%
Q2 24
0.8%
-31.4%
Capex Intensity
AAME
AAME
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
0.1%
3.4%
Q2 25
0.3%
3.5%
Q1 25
0.5%
2.7%
Q4 24
0.5%
1.7%
Q3 24
0.1%
0.4%
Q2 24
0.1%
2.0%
Cash Conversion
AAME
AAME
PRCT
PRCT
Q1 26
Q4 25
Q3 25
11.51×
Q2 25
2.80×
Q1 25
-0.90×
Q4 24
11.65×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AAME
AAME

Bankers Fidelity$30.0M56%
American Southern$23.7M44%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons